Holen Sie sich die Stockscreener-App
2.46
3.80%
0.09
Vorhandelsmarkt:
2.46
Schlusskurs vom Vortag:
$2.37
Offen:
$2.37
24-Stunden-Volumen:
1.26M
Relative Volume:
0.59
Marktkapitalisierung:
$223.54M
Einnahmen:
$70.39M
Nettoeinkommen (Verlust:
$-43.97M
KGV:
-4.7481
EPS:
-0.5181
Netto-Cashflow:
$-23.85M
1W Leistung:
+11.31%
1M Leistung:
+52.80%
6M Leistung:
-10.22%
1J Leistung:
+9.33%
1-Tages-Spanne:
$2.36
$2.485
1-Wochen-Bereich:
$2.1501
$2.485
52-Wochen-Spanne:
$0.9583
$3.87
Codexis Inc Stock (CDXS) Company Profile
Firmenname
Codexis Inc
Sektor
Branche
Telefon
650-421-8100
Adresse
200 PENOBSCOT DRIVE, REDWOOD CITY, CA
Compare CDXS vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CDXS
Codexis Inc
|
2.46 | 223.54M | 70.39M | -43.97M | -23.85M | -0.5181 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 112.35B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.71B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 52.29B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 44.48B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 35.51B | 5.36B | 287.73M | 924.18M | 2.5229 |
Codexis Inc Stock (CDXS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-08-19 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-05-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-02-29 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2023-11-07 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2023-08-07 | Herabstufung | TD Cowen | Outperform → Market Perform |
| 2023-05-09 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2022-03-31 | Fortgesetzt | Piper Sandler | Overweight |
| 2022-03-02 | Fortgesetzt | Cowen | Outperform |
| 2021-04-12 | Eingeleitet | Piper Sandler | Overweight |
| 2021-03-01 | Eingeleitet | Stifel | Buy |
| 2021-02-26 | Bestätigt | H.C. Wainwright | Buy |
| 2020-03-10 | Eingeleitet | The Benchmark Company | Buy |
| 2019-01-17 | Hochstufung | First Analysis Sec | Neutral → Outperform |
| 2018-05-16 | Eingeleitet | Stephens | Overweight |
| 2017-10-13 | Bestätigt | H.C. Wainwright | Buy |
| 2017-05-31 | Eingeleitet | Jefferies | Buy |
| 2017-01-26 | Herabstufung | First Analysis Sec | Overweight → Equal-Weight |
| 2017-01-04 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
| 2016-01-06 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Codexis Inc Aktie (CDXS) Neueste Nachrichten
Analyst sentiment unchanged after Codexis (CDXS) earnings - MSN
Integrated Millennium Group (CDXS) reports shared control of 4.73M shares - Stock Titan
Codexis Board Director Resignation and Governance Rebalancing Announced - TipRanks
Director changes and board class rebalance at Codexis (NASDAQ: CDXS) - Stock Titan
Codexis (NASDAQ:CDXS) Short Interest Drop Signals Nasdaq Composite Market Optimism - Kalkine Media
Codexis, Inc. (NASDAQ:CDXS) Short Interest Down 35.6% in March - MarketBeat
537,833 Shares in Codexis, Inc. $CDXS Purchased by Tudor Investment Corp ET AL - MarketBeat
Treasury Yields: Is Codexis Inc stock technically oversold2026 Sector Moves & Smart Money Movement Tracker - baoquankhu1.vn
Codexis, Inc. (CDXS) Stock Price Today & Analysis - Gotrade
Aug PostEarnings: Is Codexis Inc stock technically oversold2026 Market Outlook & Free Fast Entry Momentum Trade Alerts - baoquankhu1.vn
April 2026's Most Promising Penny Stocks - simplywall.st
Aberdeen Group plc Raises Stake in Codexis, Inc. $CDXS - MarketBeat
CDXS Stock Price, Quote & Chart | CODEXIS INC (NASDAQ:CDXS) - ChartMill
Codexis Faces Critical Commercialization Phase - AD HOC NEWS
CEO Moves: Should I invest in Codexis Inc before earningsPrice Action & Safe Entry Point Alerts - baoquankhu1.vn
Q3 2025 Codexis Inc Earnings Call Transcript - GuruFocus
Vanguard disaggregates holdings; Codexis Inc (NASDAQ: CDXS) shows 0 shares - Stock Titan
Institution Moves: Will Codexis Inc benefit from rising consumer demandQuarterly Trade Review & Reliable Breakout Stock Forecasts - baoquankhu1.vn
Analyst Sentiment Unchanged After Codexis (CDXS) Earnings - Insider Monkey
Codexis rises after Q4 beat, strong outlook - MSN
Benchmark reiterates Hold on Codexis stock after Q4 results By Investing.com - Investing.com India
Benchmark reiterates Hold on Codexis stock after Q4 results - Investing.com
Four Stocks at the Intersection of Enzymes, Longevity, and the $400 Billion Wellness Boom (CELV, NAGE, MTEX, CDXS) - marketscreener.com
Why did Codexis (CDXS) stock soar nearly 38% after hours? - MSN
Biocatalysis Market Accelerates with Rising Demand - openPR.com
Jobs Data: Does Codexis Inc offer margin of safety2026 Weekly Recap & Risk Controlled Swing Alerts - baoquankhu1.vn
Fund Flows: Is Codexis Inc stock technically oversold2026 Chart Watch & Weekly High Return Stock Opportunities - baoquankhu1.vn
Biocatalysis and Biocatalysts Market is expected to Hit US$ 6.7 - openpr.com
Codexis (CDXS) beats Q4 earnings and revenue estimates - MSN
Codexis (CDXS) Is Up 30.9% After Merck-Fueled Q4 Profit Beat And 2026 Revenue GuidanceHas The Bull Case Changed? - simplywall.st
Short Interest in Codexis, Inc. (NASDAQ:CDXS) Grows By 26.2% - MarketBeat
Codexis (CDXS) Is Up 30.9% After Returning To Q4 Profitability And Issuing 2026 Revenue Guidance - Yahoo Finance
Codexis Faces Strategic Challenges Amidst Revenue Dip - timothysykes.com
Assessing Codexis (CDXS) Valuation After Strong Earnings And New ECO Synthesis siRNA Agreement - simplywall.st
Finanzdaten der Codexis Inc-Aktie (CDXS)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.69%
0.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):